Tummino T, Iliopoulos-Tsoutsouvas C, Braz J, OBrien E, Stein R, Craik V
Nat Commun. 2025; 16(1):2237.
PMID: 40044644
PMC: 11882969.
DOI: 10.1038/s41467-025-57136-7.
Luttens A, Vo D, Scaletti E, Wiita E, Almlof I, Wallner O
Nat Commun. 2025; 16(1):1741.
PMID: 39966348
PMC: 11836371.
DOI: 10.1038/s41467-025-56893-9.
Liu F, Mailhot O, Glenn I, Vigneron S, Bassim V, Xu X
Nat Chem Biol. 2025; .
PMID: 39753705
DOI: 10.1038/s41589-024-01797-w.
Liu F, Wu C, Tu C, Glenn I, Meyerowitz J, Kaplan A
Science. 2024; 385(6715):eado1868.
PMID: 39298584
PMC: 11629082.
DOI: 10.1126/science.ado1868.
Diaz-Holguin A, Saarinen M, Vo D, Sturchio A, Branzell N, Cabeza de Vaca I
Sci Adv. 2024; 10(32):eadn1524.
PMID: 39110804
PMC: 11305387.
DOI: 10.1126/sciadv.adn1524.
The impact of Library Size and Scale of Testing on Virtual Screening.
Liu F, Mailhot O, Glenn I, Vigneron S, Bassim V, Xu X
bioRxiv. 2024; .
PMID: 39026784
PMC: 11257449.
DOI: 10.1101/2024.07.08.602536.
Structure-based discovery of CFTR potentiators and inhibitors.
Liu F, Kaplan A, Levring J, Einsiedel J, Tiedt S, Distler K
Cell. 2024; 187(14):3712-3725.e34.
PMID: 38810646
PMC: 11262615.
DOI: 10.1016/j.cell.2024.04.046.
Small vs. Large Library Docking for Positive Allosteric Modulators of the Calcium Sensing Receptor.
Liu F, Wu C, Tu C, Glenn I, Meyerowitz J, Kaplan A
bioRxiv. 2024; .
PMID: 38234749
PMC: 10793424.
DOI: 10.1101/2023.12.27.573448.
Docking for EP4R antagonists active against inflammatory pain.
Gahbauer S, DeLeon C, Braz J, Craik V, Kang H, Wan X
Nat Commun. 2023; 14(1):8067.
PMID: 38057319
PMC: 10700596.
DOI: 10.1038/s41467-023-43506-6.
Structure-based discovery of CFTR potentiators and inhibitors.
Liu F, Kaplan A, Levring J, Einsiedel J, Tiedt S, Distler K
bioRxiv. 2023; .
PMID: 37745391
PMC: 10515777.
DOI: 10.1101/2023.09.09.557002.
Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors.
Fink E, Bardine C, Gahbauer S, Singh I, Detomasi T, White K
Protein Sci. 2023; 32(8):e4712.
PMID: 37354015
PMC: 10364469.
DOI: 10.1002/pro.4712.
Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase.
Singh I, Li F, Fink E, Chau I, Li A, Rodriguez-Hernandez A
J Med Chem. 2023; 66(12):7785-7803.
PMID: 37294077
PMC: 10374283.
DOI: 10.1021/acs.jmedchem.2c02120.
Structure-based discovery of conformationally selective inhibitors of the serotonin transporter.
Singh I, Seth A, Billesbolle C, Braz J, Rodriguiz R, Roy K
Cell. 2023; 186(10):2160-2175.e17.
PMID: 37137306
PMC: 10306110.
DOI: 10.1016/j.cell.2023.04.010.
Targeting Oncogene Promoters and Ribosomal RNA Biogenesis by G-Quadruplex Binding Ligands Translate to Anticancer Activity.
Suseela Y, Sengupta P, Roychowdhury T, Panda S, Talukdar S, Chattopadhyay S
ACS Bio Med Chem Au. 2023; 2(2):125-139.
PMID: 37101746
PMC: 10114666.
DOI: 10.1021/acsbiomedchemau.1c00039.
In Silico Discovery of Small Molecule Modulators Targeting the Achilles' Heel of SARS-CoV-2 Spike Protein.
Wang Q, Meng F, Xie Y, Wang W, Meng Y, Li L
ACS Cent Sci. 2023; 9(2):252-265.
PMID: 36844485
PMC: 9924089.
DOI: 10.1021/acscentsci.2c01190.
Modeling the expansion of virtual screening libraries.
Lyu J, Irwin J, Shoichet B
Nat Chem Biol. 2023; 19(6):712-718.
PMID: 36646956
PMC: 10243288.
DOI: 10.1038/s41589-022-01234-w.
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2.
Gahbauer S, Correy G, Schuller M, Ferla M, Doruk Y, Rachman M
Proc Natl Acad Sci U S A. 2023; 120(2):e2212931120.
PMID: 36598939
PMC: 9926234.
DOI: 10.1073/pnas.2212931120.
Systematic Investigation of Docking Failures in Large-Scale Structure-Based Virtual Screening.
Xu M, Shen C, Yang J, Wang Q, Huang N
ACS Omega. 2022; 7(43):39417-39428.
PMID: 36340123
PMC: 9632257.
DOI: 10.1021/acsomega.2c05826.
Structure-based discovery of nonopioid analgesics acting through the α-adrenergic receptor.
Fink E, Xu J, Hubner H, Braz J, Seemann P, Avet C
Science. 2022; 377(6614):eabn7065.
PMID: 36173843
PMC: 10360211.
DOI: 10.1126/science.abn7065.
Bespoke library docking for 5-HT receptor agonists with antidepressant activity.
Kaplan A, Confair D, Kim K, Barros-Alvarez X, Rodriguiz R, Yang Y
Nature. 2022; 610(7932):582-591.
PMID: 36171289
PMC: 9996387.
DOI: 10.1038/s41586-022-05258-z.